Literature DB >> 20630860

A novel mechanism involving coordinated regulation of nuclear levels and acetylation of NF-YA and Bcl6 activates RGS4 transcription.

Jianqi Yang1, Jie Huang, Tapan K Chatterjee, Erik Twait, Rory A Fisher.   

Abstract

Neuronally enriched RGS4 plays a critical role attenuating G protein signaling in brain, although the mechanisms regulating RGS4 expression are unknown. Here we describe a novel mechanism for transcriptional activation of RGS4 in neuron-like PC6 cells, where RGS4 is markedly induced during confluence-induced growth arrest. Transcriptional activation of RGS4 in confluent PC6 cells was accompanied by impaired G(i/o)-dependent MAPK activation. In the human RGS4 gene promoter, we identified three phylogenetically conserved cis-elements: an inverted CCAAT box element (ICE), a cAMP response element, and a B-cell lymphoma 6 (Bcl6)-binding site. The ICE and the cAMP response element mediate activation, and the Bcl6 site mediates repression of RGS4 transcription. Activation of RGS4 transcription in confluent PC6 cells is accompanied by increases in NF-YA and C/EBPβ and decreases in Bcl6 levels in the nucleus. Increases in NF-YA and C/EBPβ lead to their increased binding to the RGS4 promoter in vivo, and dominant negative forms of these proteins repressed RGS4 promoter activity. Acetylation of NF-YA and Bcl6 were increased in postconfluent cells. Trichostatin A stimulation of RGS4 promoter activity, accompanied by increased binding of NF-YA and decreased binding of Bcl6 to the promoter, was abolished by mutation of the ICE and enhanced by mutation of the Bcl6 site. These findings demonstrate a dynamic and coordinated regulation of nuclear levels and acetylation status of trans-acting factors critical in determining the off/on state of the RGS4 promoter.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20630860      PMCID: PMC2943308          DOI: 10.1074/jbc.M110.121459

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression.

Authors:  R Hopfner; M Mousli; J M Jeltsch; A Voulgaris; Y Lutz; C Marin; J P Bellocq; P Oudet; C Bronner
Journal:  Cancer Res       Date:  2000-01-01       Impact factor: 12.701

2.  Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma.

Authors:  B H Ye; F Lista; F Lo Coco; D M Knowles; K Offit; R S Chaganti; R Dalla-Favera
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

3.  Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3.

Authors:  S Sinha; S N Maity; J Lu; B de Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

4.  Dominant negative analogs of NF-YA.

Authors:  R Mantovani; X Y Li; U Pessara; R Hooft van Huisjduijnen; C Benoist; D Mathis
Journal:  J Biol Chem       Date:  1994-08-12       Impact factor: 5.157

5.  BCoR, a novel corepressor involved in BCL-6 repression.

Authors:  K D Huynh; W Fischle; E Verdin; V J Bardwell
Journal:  Genes Dev       Date:  2000-07-15       Impact factor: 11.361

6.  A central role for transcription factor C/EBP-beta in regulating CD1d gene expression in human keratinocytes.

Authors:  Hashmat Sikder; Yuming Zhao; Anna Balato; Andre Chapoval; Rita Fishelevich; Padmaja Gade; Ishwar S Singh; Dhananjaya V Kalvakolanu; Peter F Johnson; Anthony A Gaspari
Journal:  J Immunol       Date:  2009-07-10       Impact factor: 5.422

7.  Isolation and characterization of a novel B cell activation gene.

Authors:  J X Hong; G L Wilson; C H Fox; J H Kehrl
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

8.  EGL-10 regulates G protein signaling in the C. elegans nervous system and shares a conserved domain with many mammalian proteins.

Authors:  M R Koelle; H R Horvitz
Journal:  Cell       Date:  1996-01-12       Impact factor: 41.582

9.  CCAAT/enhancer-binding protein alpha (C/EBPalpha) activates transcription of the human microsomal epoxide hydrolase gene (EPHX1) through the interaction with DNA-bound NF-Y.

Authors:  Qin-Shi Zhu; Bin Qian; Daniel Levy
Journal:  J Biol Chem       Date:  2004-05-17       Impact factor: 5.157

10.  Inhibition of G-protein signaling by dominant gain-of-function mutations in Sst2p, a pheromone desensitization factor in Saccharomyces cerevisiae.

Authors:  H G Dohlman; D Apaniesk; Y Chen; J Song; D Nusskern
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

View more
  6 in total

Review 1.  Regulating the regulators: Epigenetic, transcriptional, and post-translational regulation of RGS proteins.

Authors:  Mohammed Alqinyah; Shelley B Hooks
Journal:  Cell Signal       Date:  2017-10-16       Impact factor: 4.315

2.  The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases.

Authors:  Beverly W Baron; Rebecca M Baron; Joseph M Baron
Journal:  Biochim Biophys Acta       Date:  2014-12-31

3.  MEKK1-MKK4-JNK-AP1 pathway negatively regulates Rgs4 expression in colonic smooth muscle cells.

Authors:  Yonggang Zhang; Fang Li; Shu Liu; Hong Wang; Sunila Mahavadi; Karnam S Murthy; Kamel Khalili; Wenhui Hu
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

4.  Selective genomic targeting by FRA-2/FOSL2 transcription factor: regulation of the Rgs4 gene is mediated by a variant activator protein 1 (AP-1) promoter sequence/CREB-binding protein (CBP) mechanism.

Authors:  Jeff S Davies; David C Klein; David A Carter
Journal:  J Biol Chem       Date:  2011-03-02       Impact factor: 5.157

5.  RGS4 Regulates Proliferation And Apoptosis Of NSCLC Cells Via microRNA-16 And Brain-Derived Neurotrophic Factor.

Authors:  Zheng He; Lianhua Yu; Shiyi Luo; Qi Li; Shuhong Huang; Yunhe An
Journal:  Onco Targets Ther       Date:  2019-10-25       Impact factor: 4.147

6.  Association Analysis Between SNPs in the Promoter Region of RGS4 and Schizophrenia in the Northern Chinese Han Population.

Authors:  Feng-Ling Xu; Jun Yao; Xue Wu; Xi Xia; Jia-Xin Xing; Jin-Feng Xuan; Yong-Ping Liu; Bao-Jie Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-04-16       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.